GV NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Visionary Education Technology Holdings Group Inc. · Consumer Defensive · Education & Training Services

Open interactive chart View report data
Latest close 0.17 USD
-4.6% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -69.0% below the Trend Line and sits at 0.7% of its 52-week range. The latest completed week returned -4.6%, after a -14.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 56/100. Near-term considerations: volume confirmation is below normal.

Setup score 15 out of 100
Latest Close 0.17 USD 24 Jul 2026
1W Return -4.6% latest completed week
4W Return -14.9% short-term follow-through
12W Return -16.9% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 0.1x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 37.63% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -4.6% Latest completed week; four-week move -14.9%. Indicator stack 0/56 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 37.63% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 56/100 17 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -69.0% below the Trend Line and sits at 0.7% of its 52-week range. The latest completed week returned -4.6%, after a -14.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.1x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1012-week average 0.16

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.10Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -14.9% over four weeks, -16.9% over 12 weeks, and -89.2% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-4.6%
4W-14.9%
12W-16.9%
26W-86.4%
52W-89.2%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.35Latest activity-pressure read.
Pressure change-2.9%Four-week change in activity pressure.
Leadership-84.93Latest relative-leadership reading.
RS change-0.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 79% Model confidence 74%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength31/100Blend of value, momentum, and quality. Underlying universe rank 70; rank 1 is best.
Value42/100Relative valuation strength. Underlying universe rank 59; rank 1 is best.
Quality39/100Profitability and accounting quality. Underlying universe rank 62; rank 1 is best.
Momentum41/100Medium-term price momentum. Underlying universe rank 60; rank 1 is best.
Growth42/100Revenue and earnings growth. Underlying universe rank 59; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.2x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-6.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-25.6%
Gross profit retained from each unit of revenue.
Operating margin
-212.0%
Operating profit retained from revenue.
Free-cash-flow margin
-58.8%
Free cash flow generated from revenue.
Return on invested capital
-15.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
2/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-5.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment56/100

Weighted news tone is neutral across 17 relevant articles.

5 positive · 12 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-96.0%Distance below the 52-week high.
13-week volatility16.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher6 of 2620 weeks finished lower.
Best week+123.1%Week of 3 Apr.
Worst week-44.1%Week of 27 Mar.
Latest week-4.6%Week of 24 Jul.

Shape of recent returns

Strong gains3
Modest gains3
Flat weeks0
Modest losses4
Sharp losses16
Recent vol16.4%13-week weekly-return volatility.
Base vol24.4%52-week weekly-return volatility.
Up/down split18/34Count of positive and negative weeks in the 52-week window.
Average skew17.6% / -12.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape17/100

Trend, activity pressure, participation, and risk combine to a 17/100 tape read.

 Indicator analysis22/100

Latest 12-week confirmation: trend 0/12, activity pressure 7/12, relative leadership 0/12.

Activity pressure 0.10; No reversal markers Next-Week ExpectancyNegative 37.63%

Next-week expectancy is negative with a 37.63% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors37/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 52 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment56/100

Weighted news tone is neutral across 17 relevant articles.

Aptech Ltd Q1 FY27: Profit Surge Masks Margin Pressures as Education Services Provider Navigates Recovery Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20260.17 USD-4.6%0.54 USD2.03 USD0.35-84.93558.9KOff
17 Jul 20260.17 USD-2.1%0.57 USD2.06 USD0.36-84.91335.5KOff
10 Jul 20260.18 USD-7.5%0.61 USD2.10 USD0.38-85.68544.8KOff
3 Jul 20260.19 USD-1.5%0.65 USD2.13 USD0.44-84.75601.7KOff
26 Jun 20260.20 USD-5.4%0.69 USD2.17 USD0.36-84.835.3MOff
19 Jun 20260.21 USD-1.7%0.74 USD2.21 USD0.27-85.141.2MOff
12 Jun 20260.21 USD-12.1%0.77 USD2.25 USD0.11-84.972.6MOff
5 Jun 20260.24 USD-27.7%0.81 USD2.30 USD-0.11-83.042.0MOff
29 May 20260.33 USD0.9%0.85 USD2.34 USD-0.39-78.361.8MOff
22 May 20260.33 USD36.0%0.89 USD2.38 USD-0.66-78.604.5MOff
15 May 20260.24 USD32.7%0.93 USD2.43 USD-0.86-84.5867.0MOff
8 May 20260.18 USD-9.3%0.98 USD2.48 USD-0.96-88.7636.0MOff
1 May 20260.20 USD0.0%1.02 USD2.55 USD-0.95-87.292.5MOff
24 Apr 20260.20 USD-9.9%1.09 USD2.61 USD-0.85-87.486.4MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context